AETERNA ZENTARIS INC (AEZS) Stock News

NASDAQ:AEZS - Nasdaq - CA0079756007 - Common Stock - Currency: USD

5.72 +0.32 (+5.93%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AEZS Latest News, Press Relases and Analysis

All

Press Releases

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

a year ago - By: Ademi LLP

Shareholder Alert: Ademi LLP investigates whether Aeterna Zentaris Inc.'s transaction with Ceapro was Fair to Shareholders

a year ago - By: Ceapro Inc. - Mentions: CZO.CA AEZS.CA

Aeterna Zentaris and Ceapro Complete Merger Transaction

a year ago - By: BusinessInsider

News Image

AEZS Stock Earnings: AEterna Zentaris Misses EPS, Misses Revenue for Q1 2024

a year ago - By: InvestorPlace

AEZS Stock Earnings: AEterna Zentaris Misses EPS for Q4 2023

a year ago - By: Benzinga

AEterna Zentaris: Q4 Earnings Insights

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris and Ceapro Complete Merger Transaction

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Announces Details Regarding Transaction with Ceapro

a year ago - By: InvestorPlace

AEZS Stock Earnings: AEterna Zentaris Misses EPS, Misses Revenue for Q1 2024

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Reports First Quarter 2024 Financial Results

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Announces Effective Date of Share Consolidation

3 years ago - By: Benzinga - Mentions: NVO

Aeterna Zentaris Shelves Early-Stage Vaccine Programs, Including COVID-19

a year ago - By: Ceapro Inc. - Mentions: CZO.CA AEZS.CA

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

a year ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

a year ago - By: Ceapro Inc.; Aeterna Zentaris Inc. - Mentions: CZO.CA AEZS.CA

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

a year ago - By: Ceapro Inc. - Mentions: CZO.CA AEZS.CA

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

1 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

1 years ago - By: Seeking Alpha

Aeterna Zentaris files to sell 2.53M warrants (NASDAQ:AEZS)

2 years ago - By: Halper Sadeh LLC

AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders

2 years ago - By: Seeking Alpha

Aeterna Zentaris and Ceapro to merge in all-stock deal

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Reports Second Quarter 2023 Financial Results

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Reports First Quarter 2023 Financial Results

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT Trial

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results

2 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)

3 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones

3 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch Event

3 years ago - By: Aeterna Zentaris Inc - Mentions: AEZS.CA

Aeterna Zentaris Reports Third Quarter 2022 Financial Results